Prognosis of patients with wild‐type transthyretin cardiac amyloidosis and non‐sustained ventricular tachycardia
NSVT is highly prevalent among ATTRwt-CA patients undergoing clinically indicated Holter monitoring and may confer an increased risk of incident sustained VA.
Authors
- Angela A. Dispenzieri (ORCID: https://orcid.org/0000-0001-8780-9512)
- Konstantinos C. Siontis (ORCID: https://orcid.org/0000-0002-6658-0971)
- Peter A. Noseworthy (ORCID: https://orcid.org/0000-0002-4308-0456)
- Omar F. Abou Ezzeddine
- Grace Lin (ORCID: https://orcid.org/0000-0002-8087-1150)
- William H. Swain
- Nicholas Y. Tan (ORCID: https://orcid.org/0000-0002-0365-9471)
- Ojasav Sehrawat (ORCID: https://orcid.org/0000-0002-6254-0104)
- Hannah P. Alcantara
- Martha Grogan
Institutions
- Mayo Clinic (US)
Publication Details
- Journal
- Journal of Cardiovascular Electrophysiology
- Published
- 2024-11-06
- DOI
- https://doi.org/10.1111/jce.16470
- Citations
- 2
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.47